• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏再同步治疗植入术后心力衰竭患者的设备调整与恢复:一项纵向研究

Device Adjustment and Recovery in Patients With Heart Failure Undergoing a Cardiac Resynchronization Therapy Implantation: A Longitudinal Study.

作者信息

Thylén Ingela, Jaarsma Tiny, Ingadottir Brynja

出版信息

J Cardiovasc Nurs. 2022;37(3):221-230. doi: 10.1097/JCN.0000000000000795.

DOI:10.1097/JCN.0000000000000795
PMID:33657066
Abstract

BACKGROUND

Little is known about risk factors for poor adjustment to the device after cardiac resynchronization therapy (CRT) implantation in patients with heart failure.

PURPOSE

The aim of this study was to explore device adjustment and the postoperative recovery of patients with heart failure undergoing elective CRT device implantation.

METHODS

In this prospective multicenter longitudinal study, data were collected before implantation and after 2 weeks, 6 months, and 1 year, using validated self-reported instruments and investigator-designed, CRT-specific questions.

RESULTS

A total of 133 patients, 79% male, with a mean age of 70 ± 10 years, were included. Patients adjusted to the device over time (P < .001), but 20% of patients had difficulties after 2 weeks, and 11% had difficulties at the 1-year follow-up. Fatigue was the most common health problem before surgery (87%), which was reduced to 65% after 1 year, P < .001. Patients' recovery improved over time (P < .001). Device-specific problems with hiccups (7% vs 14%), pulsation around the device (29% vs 24%), tachycardia (28% vs 29%), appearance of the scar (21% vs 17%), and the device bulging out (65% vs 61%) remained unchanged over time, whereas stiffness in the shoulder (64% vs 28%, P < .001) and wound healing (9% vs 2%, P < .05) improved.

CONCLUSIONS

Most patients with heart failure recover and adjust early after their CRT implantation and improve even more during follow-up. However, recovery and adjustment are problematic for some patients, and many experience bodily discomforts because of the device. Early screening for poor adjustment and psychological distress can lead to appropriate interventions and timely referrals. This is important in the era of remote monitoring with less face-to-face contact.

摘要

背景

对于心力衰竭患者心脏再同步治疗(CRT)植入术后对设备适应不良的风险因素知之甚少。

目的

本研究旨在探讨接受择期CRT设备植入的心力衰竭患者的设备适应情况及术后恢复情况。

方法

在这项前瞻性多中心纵向研究中,使用经过验证的自我报告工具和研究者设计的CRT特定问题,在植入前以及植入后2周、6个月和1年收集数据。

结果

共纳入133例患者,男性占79%,平均年龄为70±10岁。患者随时间推移逐渐适应设备(P<.001),但20%的患者在2周后仍有困难,11%的患者在1年随访时有困难。疲劳是手术前最常见的健康问题(87%),1年后降至65%,P<.001。患者的恢复情况随时间改善(P<.001)。与设备相关的问题,如打嗝(7%对14%)、设备周围搏动(29%对24%)、心动过速(28%对29%)、疤痕外观(21%对17%)以及设备突出(65%对61%)随时间保持不变,而肩部僵硬(64%对28%,P<.001)和伤口愈合(9%对2%,P<.05)有所改善。

结论

大多数心力衰竭患者在CRT植入术后早期恢复并适应,且在随访期间改善更为明显。然而,部分患者的恢复和适应存在问题,许多患者因设备而出现身体不适。早期筛查适应不良和心理困扰可导致适当干预和及时转诊。在远程监测且面对面接触较少的时代,这一点很重要。

相似文献

1
Device Adjustment and Recovery in Patients With Heart Failure Undergoing a Cardiac Resynchronization Therapy Implantation: A Longitudinal Study.心脏再同步治疗植入术后心力衰竭患者的设备调整与恢复:一项纵向研究
J Cardiovasc Nurs. 2022;37(3):221-230. doi: 10.1097/JCN.0000000000000795.
2
Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.植入式心脏除颤器联合心脏再同步化治疗与单纯心脏再同步化治疗的增量效益。
Heart. 2017 Dec;103(24):1977-1984. doi: 10.1136/heartjnl-2017-311423. Epub 2017 Jul 17.
3
Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.采用一套新型检测算法减少心脏再同步治疗除颤器治疗的心力衰竭患者不适当的抗心动过速起搏治疗和电击:前瞻性数据库的历史对照研究
Europace. 2016 Sep;18(9):1391-8. doi: 10.1093/europace/euv420. Epub 2016 Jan 29.
4
Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.在 TRUST CRT 随机试验的一项子研究中,观察到在接受三部位心脏再同步治疗的患者中,1 年随访期间的植入可行性、与手术相关的不良事件和导联性能。
J Cardiovasc Electrophysiol. 2012 Nov;23(11):1228-36. doi: 10.1111/j.1540-8167.2012.02375.x. Epub 2012 May 31.
5
Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator.使用和不使用植入式心脏复律除颤器的心脏再同步治疗中的机构层面差异与临床结局
Circ Cardiovasc Qual Outcomes. 2018 Dec;11(12):e004763. doi: 10.1161/CIRCOUTCOMES.118.004763.
6
The European Society of Cardiology Cardiac Resynchronization Therapy Survey II: A comparison of cardiac resynchronization therapy implantation practice in Europe and France.《欧洲心脏病学会心脏再同步治疗调查 II:欧洲与法国心脏再同步治疗植入实践的比较》。
Arch Cardiovasc Dis. 2019 Nov;112(11):713-722. doi: 10.1016/j.acvd.2019.09.005. Epub 2019 Nov 6.
7
Ventricular Electrical Delay Measured From Body Surface ECGs Is Associated With Cardiac Resynchronization Therapy Response in Left Bundle Branch Block Patients From the MADIT-CRT Trial (Multicenter Automatic Defibrillator Implantation-Cardiac Resynchronization Therapy).从体表心电图测量的心室电延迟与 MADIT-CRT 试验(多中心自动除颤器植入-心脏再同步治疗)中左束支传导阻滞患者的心脏再同步治疗反应相关。
Circ Arrhythm Electrophysiol. 2018 May;11(5):e005719. doi: 10.1161/CIRCEP.117.005719. Epub 2018 Apr 26.
8
Amiodarone is associated with adverse outcomes in patients with sustained ventricular arrhythmias upgraded to cardiac resynchronization therapy-defibrillators.胺碘酮与升级为心脏再同步治疗除颤器的持续性室性心律失常患者的不良结局相关。
J Cardiovasc Electrophysiol. 2019 Mar;30(3):348-356. doi: 10.1111/jce.13828. Epub 2019 Jan 4.
9
Selection and outcome of implantable cardioverter-defibrillator patients with and without cardiac resynchronization therapy: Comparison of 4384 patients from the German Device Registry to randomized controlled trials.接受和未接受心脏再同步治疗的植入式心脏复律除颤器患者的选择及预后:德国器械注册中心4384例患者与随机对照试验的比较
J Cardiovasc Electrophysiol. 2022 Mar;33(3):483-492. doi: 10.1111/jce.15365. Epub 2022 Jan 23.
10
Continued versus Suspended Cardiac Resynchronization Therapy after Left Ventricular Assist Device Implantation.继续或暂停左心室辅助装置植入后的心脏再同步治疗。
Sci Rep. 2020 Feb 13;10(1):2573. doi: 10.1038/s41598-020-59117-w.